ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

Government Offers Two Approval Standards For Assays: CLIA, FDA

January 30, 2009

FDA News: Consolidation Plan Designed For Savings

June 5, 1998

Pittsburgh Cancer Institute Wins SPORE Grant For Lung Cancer, For Three Major Projects.

July 20, 2001

Brandt Tells NIK There May Be No Exceptions To DRG Regulations, Maybe a Few At Comprehensive Centers

June 24, 1983

Sen. Pryor Attacks Drug Industry, NIH Technology Transfer

March 5, 1993

In Brief: Carter Transition Team Lists Prospects For HEW Secretary; Interferon Available

December 3, 1976